摘要
结缔组织病相关肺动脉高压是常见肺动脉高压之一,其发病机制复杂,预后较差。近年来,随着对结缔组织病相关肺动脉高压的认识越来越深入和靶向药物的不断发展,对结缔组织病相关肺动脉高压的诊断和治疗取得了新的进展,早期诊断、早期治疗可显著控制病情、改善预后。
Connective tissue disease (CID)-related pulmonary arterial hypertension (PAH) is one of frequent PAH, whose pathogenesis is complicated and prognosis is poor. In recent years, with deepening understanding of CID-related PAH and development of targeted drugs, diagnosis and treatment of CID-related PAH achieve new progress, and early diagnosis and treatment can significantly control disease condition and improve prognosis.
作者
景驰
吴炳祥
JING Chi;WU Bing-xiang(Department of Cardiology, Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, China)
出处
《心血管康复医学杂志》
CAS
2019年第3期369-372,共4页
Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词
高血压
肺性
结缔组织疾病
诊断
Hypertension, pulmonary
Connective tissue diseases
Diagnosis
